Skip to main content

Please note that this is a beta version of our website. Should you encounter any bugs, glitches, lack of functionality or other problems on the website, please let us know immediately so we can rectify these accordingly. Your help in this regard is greatly appreciated! You can email us.

Login to North West London Pathology – consumables service

If you need a new account or you have a query about your order, please telephone the pathology call centre on 0203 313 5353.

If you have forgotten your password you can reset this yourself. Please click here if you have forgotten your password.

Results Line and Enquiries

0203 313 5353

MPN panel (next generation sequencing)

Category Specialist Integrated Haematological Malignancy Diagnostic Service (SIHMDS) >> Molecular Pathology
Test background

A targeted NGS panel used for prognostic and predictive testing in myeloproliferative neoplasms.

This assay comprises of 79 amplicons in 13 genes frequently mutated in myeloid malignancies. The regions and the reference sequences covered by this panel are ASXL1 (exon 13; NM_015338.5); CALR (exon 9; NM_004343.3); CBL (exons 8+9; NM001130852.1); CBLB (exons 9+10; NM_001321811.1); CBLC (exons 9+10; NM_012116.3); CSF3R (exons 14 to 18; NM_012433.3); EZH2 (exons 2 to 20; NM_001203247.1); IDH1 (exon 4; NM_001282387.1); IDH2 (exon 4; NM_001289910.1); JAK2 (exons 12 +14; NM_001322195.1); JAK3 (exons 13; NM_000215.3); MPL (exons 10; NM_005373.2); SETBP1 (exon 4 partial; NM_015559.2); SF3B1 (exons 13-16; NM_012433.2).

Clinicial Indications

Investigation of suspected (philadelphia chromosome negative) myeloproliferative neoplasms polycythemia vera, essential thrombocythemia and myelofibrosis.

Sample & container required 4ml Blood or bone marrow in EDTA (lavender/purple top)
Turnaround time 21 working days